Valorisations sectorielles Stoke Therapeutics, Inc.

Actions

STOK

US86150R1077

Recherche biotechnologique et médicale

Temps réel estimé Cboe BZX Autres places de cotation 16:35:12 17/06/2026			Varia. 5j.	Varia. 1 janv.
30,23 ^USD	+3,70%		+6,64%	-4,32%

08/06	Transcript : Stoke Therapeutics, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 10:40 AM
08/05	Transcript : Stoke Therapeutics, Inc., Q1 2026 Earnings Call, May 07, 2026

Secteur:

Région:

Axe X:

Principaux concurrents

Ajouter à une liste 0 sélectionné Pour utiliser cette fonction vous devez être client ou membre Connexion Inscription	PER (Y)	Price to Book (Y)	PEG (Y)	VE / CA (Y)	VE / EBITDA (Y)	VE / EBIT (Y)	Rendement du dividende (Y)	Capi.($)
STOKE THERAPEUTICS, INC.	-8.87x	6.81x	-0x	58.39x	-7.64x	-6.9x	-	1,82 Md
LONZA GROUP AG	29.85x	3.82x	1.32x	5.29x	16.41x	23.03x	1,1%	43,51 Md
REVOLUTION MEDICINES, INC.	-19.69x	14.37x	-0.59x	291.06x	-17.93x	-17.62x	-.--%	33,29 Md
BEONE MEDICINES AG	39.37x	5.87x	0.24x	3.9x	24.99x	29.58x	-.--%	29,34 Md
IQVIA HOLDINGS INC.	21.8x	4.13x	4.52x	2.52x	10.89x	16.6x	-.--%	29,9 Md
CELLTRION, INC.	29.49x	2.19x	0.88x	7.59x	19.52x	23.3x	0,4%	25,42 Md
MEDPACE HOLDINGS, INC.	27.09x	13.57x	2.36x	4.34x	19.75x	20.71x	-.--%	13,18 Md
EUROFINS SCIENTIFIC SE	21.78x	2.28x	0.75x	1.9x	8.34x	13.21x	1,22%	12,72 Md
IONIS PHARMACEUTICALS, INC.	-20.24x	301.86x	-0.39x	13.32x	-19.83x	-19.28x	-.--%	12,08 Md
ICON PUBLIC LIMITED COMPANY	22.84x	1.12x	0.2x	1.66x	10.02x	11.47x	-.--%	10,99 Md
TEMPUS AI, INC.	-25.11x	22.4x	-0.59x	6.1x	149.67x	-471x	-.--%	9,08 Md
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	30.12x	2.7x	-0.1x	2.78x	10.86x	13.17x	-.--%	8,9 Md
BIO-TECHNE CORPORATION	48.05x	4.07x	0.31x	7.2x	20.42x	22.46x	0,57%	8,77 Md
ABIVAX	-21.72x	37.75x	1.07x	1644.23x	-23.46x	-24.03x	-.--%	7,73 Md
QIAGEN N.V.	17.75x	2.02x	2.2x	3.81x	10.16x	13.01x	-.--%	7,7 Md
ALKERMES PLC	-111.06x	3.99x	0.87x	4.59x	24.33x	145.97x	-.--%	7,35 Md
PRAXIS PRECISION MEDICINES, INC.	-16.9x	6.4x	-1.31x	1474.22x	-13.91x	-13.22x	-.--%	7,17 Md
PROTAGONIST THERAPEUTICS, INC.	28.38x	-	-0.1x	12.85x	22.89x	24.89x	-.--%	7,12 Md
Moyenne	5,16x	25,61x	0,65x	196,99x	14,75x	-10,81x	0,19%	15,34 Md
Moyenne pondérée par Capi.	12,75x	20,53x	0,94x	124,04x	13,29x	-0,72x	0,29%